Patents by Inventor Paul John Phillips

Paul John Phillips has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040006097
    Abstract: The present invention relates to the compound of formula (I): or a pharmaceutically acceptable salt or an in vivo hydrolysable ester thereof. This compound of formula (I) is conveniently called: (E)-7[4-(4-fluorophenyl)-6-isopropyl-2-mesylaminopyrimidin-5-yl]-(3R,5S)-dihydroxyhept-6-enoic acid.
    Type: Application
    Filed: October 18, 2002
    Publication date: January 8, 2004
    Inventors: Steven James Hill, Eva Maria Lenz, Paul John Phillips
  • Patent number: 5668137
    Abstract: The invention concerns pharmaceutically useful compounds of the formula I, in which R.sup.1, R.sup.2, R.sup.3, n, m and Het have any of the meanings defined herein, and their pharmaceutically-acceptable salts, and pharmaceutical compositions containing them. The novel compounds possess endothelin receptor antagonist activity and are useful, for example, in the treatment of diseases or medical conditions in which elevated or abnormal levels of endothelin play a significant causative role. The invention further concerns processess for the manufacture of the novel compounds and the use of the compounds in medical treatment.
    Type: Grant
    Filed: June 20, 1996
    Date of Patent: September 16, 1997
    Assignee: Zeneca Ltd.
    Inventors: Paul John Phillips, Peter Grahame Ballard, Robert Hugh Bradbury, Roger James